CoreCap Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

CoreCap Advisors’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10K	Hold	534	–	–	﹤0.01%	2054
2026 Q2	$10.7K	Hold	534	–	–	﹤0.01%	2044
2026 Q1	$8.69K	Hold	534	–	–	﹤0.01%	1995
2025 Q4	$8.96K	Sell	534 -350	-40%	-$5.88K	﹤0.01%	2004
2025 Q3	$13.7K	Hold	884	–	–	﹤0.01%	1806
2025 Q2	$11.3K	Hold	884	–	–	﹤0.01%	1820
2025 Q1	$11.2K	Hold	884	–	–	﹤0.01%	1769
2024 Q4	$11.6K	Hold	884	–	–	﹤0.01%	1718
2024 Q3	$13.3K	Hold	884	–	–	﹤0.01%	1703
2024 Q2	$12.5K	Hold	884	–	–	﹤0.01%	1020
2024 Q1	$12K	Buy	+884	New	+$12.2K	﹤0.01%	1685
2022 Q4	$9.7K	Buy	+682	New	+$9.9K	﹤0.01%	1552
2022 Q3	–	Sell	-559	Closed	-$8K	–	1195
2022 Q2	$8K	Buy	+559	New	+$8.44K	﹤0.01%	1537
2022 Q1	–	Sell	-600	Closed	-$12K	–	1204
2021 Q4	$12K	Buy	+600	New	+$12.1K	﹤0.01%	1491

Other funds holding HQL

Decision Investments San Diego, California $110M AUM 52.83% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

CoreCap Advisors's HQL Position: Q3 2026 in Review

CoreCap Advisors held its abrdn Life Sciences Investors (HQL) position steady in Q3 2026 at 534 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2054.

CoreCap Advisors first reported a position in HQL in Q4 2021 and has held it in 14 quarters since. The position peaked at $13.7K in Q3 2025. 4 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

CoreCap Advisors held 534 shares of abrdn Life Sciences Investors worth $10K as of Q3 2026.
CoreCap Advisors left its abrdn Life Sciences Investors share count unchanged in Q3 2026.
abrdn Life Sciences Investors made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2054 holding.
CoreCap Advisors first reported a position in abrdn Life Sciences Investors in Q4 2021 and has held it in 14 quarters since.
CoreCap Advisors's abrdn Life Sciences Investors position peaked at $13.7K in Q3 2025.
4 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.